The Earliest T Lineage–Committed Cells Depend on IL-7 for Bcl-2 Expression and Normal Cell Cycle Progression  by von Freeden-Jeffry, Ursula et al.
Immunity, Vol. 7, 147±154, July, 1997, Copyright 1997 by Cell Press
The Earliest T Lineage±Committed Cells
Depend on IL-7 for Bcl-2 Expression
and Normal Cell Cycle Progression
Ursula von Freeden-Jeffry, Nanette Solvason, 1995; Murray, 1996). Although interleukin-2 (IL-2), IL-4,
IL-7, IL-9, and IL-15 share the gc chain for binding, IL-7Maureen Howard, and Richard Murray
is unique and nonredundant in its capacity to maintainDepartment of Immunobiology
and/or expand both T and B cells to normal numbersDNAX Research Institute
(von Freeden-Jeffry et al., 1995). The lymphopenia in901 California Avenue
IL-7±deficient mice is similar to that of mice deficient inPalo Alto, California 94304
either the gc receptor (Cao et al., 1995; DiSanto et al.,
1995), the IL-7 receptor (IL-7R) (Peschon et al., 1994),
or Jak3 (Nosaka et al., 1995; Park et al., 1995; ThomisSummary
et al., 1995). Mutation of gc and Jak3 in mice each results
in the collective functional elimination of at least fiveInterleukin-7 (IL-7)±deficient mice exhibit an early
cytokine ligands, and IL-7R mutant mice cannot bind atdefect in lymphopoiesis. We examined Bcl-2 expres-
least two independent ligands. Thus, comparison ofsion and the cell cycle status of immature thymocyte
mice mutant for common receptors or signal transduc-subsets in these mice. In IL-7±deficient mice, develop-
tion molecules with mice mutant for each of the individ-mental transition to a T cell±committed fate was ac-
ual ligands is critical for clarification of redundant versuscompanied by a striking loss of Bcl-2 protein expres-
nonredundant function among ligand families.sion and an increased relative proportion of cells in
The complexities of lymphoid generation and devel-the G0/G1 stage of the cell cycle. Short-term culture
opment have been extensively delineated within theof immature thymocytes with rIL-7 caused up-regula-
thymus (Godfrey and Zlotnik, 1993; Shortman and Wu,tion of Bcl-2 protein and cell survival. These data spec-
1996). The earliest steps of progenitor differentiationify a T cell lineage developmental transition point, prior
within the thymus have been classified into five pheno-to T cell antigen receptor rearrangement, where IL-7
typically distinct subpopulations, designated A throughsignal transduction is linked to an anti-apoptosis
E in this report, as defined in Table 1. These subpopula-mechanism and the cell cycle.
tions are primarily distinguished in terms of T lineage
commitment and rearrangement of one or more chains
Introduction of the T cell antigen receptor (TCR). In this context the
RAG-1 and RAG-2 gene products, essential for antigen
The developmental expansion and steady-state mainte- receptor recombination events (Mombaerts et al., 1992;
nance of cellularity in any given tissue is the net result of Shinkai et al., 1992), are expressed at the transition of
a counterbalance of positive and negative mechanisms. population C (triple-negative [TN] CD441CD251) to D
This is particularly evident in the lymphoid system, (TN CD442CD251) (Godfrey and Zlotnik, 1993). The pre-
where a continuously renewing source of T and B lym- TCR complex (TCRb chain and gp33), critical for an early
phocytes must balance proliferation, developmental stage of positive selection, is subsequently expressed
expansion, selection against autoreactivity, and anti- (Groettrup et al., 1993; von Boehmer, 1994). TCRg chain
gen-driven clonal expansion and diminution for appro- rearrangement is also initiated during this same transi-
priate function. A key issue is now to understand how tion step (Godfrey and Zlotnik, 1993; Shortman and Wu,
these mechanisms interact at specific points in lineage 1996). The overlapping time frames of IL-7 signaling, T
development. cell commitment, and TCR rearrangement underscore
The Bcl-2 family represents a group of genes that the importance of understanding the integration of
function in antagonizing or agonizing apoptosis (Cory, mechanisms of cell growth, maintenance, and devel-
1995; Korsmeyer, 1995). Bcl-2, the Ced-9 homolog of opment.
Caenorhabditis elegans, inhibits some but not all forms We have shown that the thymus of IL-7±deficient mice
of stimuli that induce apoptosis (Hawkins and Vaux, is strikingly reduced in size but retains normal CD4 and
1994; Vaux et al., 1994; White, 1996). Bcl-2±deficient CD8 ratios, suggesting that a mechanistic defect must
mice display a complex phenotype and die within weeks occur earlier in development. We then investigated TN
to months after birth, making detailed analysis of ongo- thymocytes from IL-7±deficient mice, separated into
ing lymphopoiesis difficult (Veis et al., 1993b; Nakayama developmentally staged populations B through E (Table
et al., 1994; Kamada et al., 1995). Interestingly, Bcl- 1), and found that IL-7±deficient mice showed a relative
2±deficient mice exhibit some phenotypic similarities to increase in populations B (TN CD441CD252), C (TN
IL-7±deficient mice in terms of defects associated with CD441CD251), and D (TN CD442CD251), implying a re-
lymphoid development and maintenance. Both mutant duced efficiency in the completion of these develop-
mice show reduced lymphoid lineages, while other he- mental steps (Moore et al., 1996).
matopoietic cell types are normal in number and distri- The current study investigates a mechanistic rela-
bution (Nakayama et al., 1993; von Freeden-Jeffry et al., tionship between IL-7 and cell maintenance and pro-
1995; Matsuzaki et al., 1997). liferation during the early developmental stages of
The cytokine-driven expansion and/or maintenance thymocytes (Table 1, subsets B through E). It has been
of murine lymphocytes is dependent primarily on signals established that Bcl-2 is expressed at the double-nega-
generated via the common g (gc) chain cytokine recep- tive (DN) and single-positive (SP) stage of thymocytes,
but not inmost double-positive (DP) cells (Gratiot-Deanstor/Jak/STAT pathway (Leonard et al., 1995; Lin et al.,
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Table 1. Early Thymic Subpopulations
Phenotype Subset Designation Developmental Potential Other Characteristics
CD32CD4loCD82 A Multiple lineages Bone marrow derived
TN CD32CD42CD82
CD441CD252 B Multiple lineages TCRb germline
TCRg germline
CD441CD251 C T cell restricted TCRb germline
TCRg germline
CD442CD251 D T cell restricted TCRb rearrangement
TCRg rearrangement
CD442CD252 E T cell restricted TCRb rearrangement
TCRg rearrangement
Definition of early thymic subpopulations and the data to support the characterizations shown are found in Shortman and Wu (1996) and
Godfrey and Zlotnik (1993).
et al., 1993; Veis et al., 1993a; Moore et al., 1994). To showed a relative increase in the proportions of subsets
B (TN CD441CD252), C (TN CD441CD251), and D (TNdefine more precisely the relationship between IL-7 and
Bcl-2 in earlier T cell development, we analyzed the four CD442CD251) similar to data we have previously de-
scribed (Moore et al., 1996). These data implied a roleTN CD44 and CD25 subsets from IL-7±deficient mice
for expression of Bcl-2 protein, the status of the cell for IL-7±related functions prior to or during TCR re-
arrangement. To investigate this issue decisively we in-cycle, and levels of apoptosis. Our results indicate that
Bcl-2 expression becomes dependent on IL-7 when tercrossed IL-7±deficient mice with RAG-2±deficient
mice, restricting the thymic populations to cells prior tocells become committed to theT cell lineage, population
C, (TN CD441CD251). Furthermore, we show that this TCR rearrangement. The doubly deficient mutant mice
exhibited a thymus almost devoid of thymocytes, in con-defect is also accompanied by variations in the cell cycle
occurring at precisely the same stage of development. trast to wild-type or each single-gene±deficient thymus
(Figure 2). These results indicate that thymocyte popula-We discuss the implications of an IL-7/Bcl-2/cell cycle
pathway during stages of thymocyte development tions prior to TCR rearrangement depend largely on IL-7
as a stimulus.where TCR rearrangement is initiated.
Results
Bcl-2 Expression Depends on IL-7 at the
Commitment to the T LineageIL-7 Is Critical for Thymocyte Development
Given the shift in phenotype among TN cells, as wellPrior to TCR Rearrangement
as the confirmation of the role for IL-7 prior to TCR
Because IL-7±deficient mice exhibited a profound de-
rearrangement, we examined the TN CD44 and CD25
crease in theoverall number of thymocytes but no signif-
subsets for a mechanistic defect linked to IL-7 signaling.
icant difference in CD4/CD8 staining profile, we rea-
We examined the entire TN population, as well as each
soned that a mechanistic defect occurred very early in
of the TN CD44 and CD25 subsets, for Bcl-2 expression.
thymic lineage development. Figure 1 shows fluores-
Figure 3 shows that the entire TN population from
cence-activated cell sorter (FACS) staining for expres-
IL-7±deficient mice is largely devoid of Bcl-2 protein
sion of CD44 and CD25 subsets of TN cells from
when compared to the equivalent population of cells
IL-7±deficient and wild-type mice. IL-7±deficient mice
from wild-type mice. However, a small shoulder of Bcl-
2±positive cells existed in the IL-7±deficient TN popula-
tion (see below). Subdividing the TN cells revealed that
the earliest subset analyzed, the multipotential popula-
tion B (TN CD441CD252), exhibited a similar biphasic
Bcl-2 expression pattern for both wild-type and IL-7±
deficient cells. Transition tosubset C (TN CD441CD251),
consisting of cells committed to the T cell lineage (Moore
and Zlotnik, 1995), was accompanied by loss of Bcl-2
expression in IL-7±deficient mice, whereas wild-type
mice were almost uniformly Bcl-2 positive. This same
differential expression pattern was maintained in the
subsequent developmental populations, subset D (TN
CD442CD251) and subset E (TN CD442CD252). The
Figure 1. Analysis of TN Subpopulations in the Thymi of IL-7±Defi- staining pattern in the control mice reported here is
cient and Wild-Type Mice similar to result described for fetal day 15.5 thymus (Veis
Cells were isolated from 3- to 4-week-old IL-7±deficient (IL-72/2) et al., 1993a). The small shoulder of Bcl-2 staining in
and wild-type mice and purified as described. Total thymus cell the entire TN population from IL-7±deficient mice was
numbers were 0.30 6 0.16 3 108 in IL-7±deficient mice and 3.85 6
probably the contribution of population B (TN CD4411.42 3 108 in wild-type mice. The recovery of TN thymocytes was
CD252), the small subset of multipotential cells in whichbetween 0.3 and 0.9% of total thymus cells. The results shown are
representative data from 10 experiments. Bcl-2 expression was unchanged. The most mature
T Cells Depend on IL-7 for Bcl-2 Expression
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Figure 2. SizeComparison of Thymi from Wild-Type, IL-7±Deficient,
RAG-2±Deficient, and Doubly Deficient Mice
The data are shown as pictures of both thymic lobes from represen-
tative animals, because accurate cell counts were difficult to deter-
mine from doubly mutant mice. All animals were 5 weeks old.
subset analyzed here, subset E (TN CD442CD252), from
wild-type mice appeared to be down-regulating Bcl-2,
consistent with cells nearing the transition to DP.
Reduced Bcl-2 Expression Correlates
with Increased Apoptosis
A reduction in Bcl-2 expression would predict an in-
crease in apoptotic cells. We examined the entire TN
thymocyte subset for levels of apoptosis as indicated
by annexin V staining. Figure 4A shows a representative
experiment in which TN cells from wild-type and
IL-7±deficient mice were compared bystaining with both
propidium iodide (PI) and annexin V. IL-7±deficient mice
showed an increase in annexin V±positive cells that form
a gradient of PI staining from negative to positive (i.e.,
cells in the process of apoptosis to cells completing
apoptosis [Vermes et al., 1995]). Figure 4B shows the
average of three independent experiments and repre- Figure 3. Bcl-2 Expression on TN Thymocytes from IL-7±Deficient
and Wild-Type Micesents annexin V±positive staining of both PI-positive
Total TN thymocytes were purified as described; stained with anti-and PI-negative TN cells from wild-type or IL-7±deficient
CD44, anti-CD25, and anti-Bcl-2; and analyzed by flow cytometry.mice. We conclude that IL-7±deficient mice exhibited a
The Bcl-2 expression in total TN thymocytes and in the gated four TNreproducible increase in apoptosis from freshly isolated
subpopulations (subset B, CD441CD252; subset C, CD441CD251;
TN cells, detectable prior to removal of dead cells by a subset D, CD442CD251; and subset E, CD442CD252) from IL-7±
well-appreciated but uncharacterizedclearance mecha- deficient mice (shaded areas) and wild-type mice (open areas) are
nism in the thymus. shown. Background staining is shown by matched isotype control
antibody (top graph, lightface line). Note the different scales on
the y axis, representing the relative cell numbers of the differentIL-7±Deficient TN Thymocyte Subsets Show
subpopulations. The data are representative results from four exper-Reduced Progression of the Cell Cycle
iments.IL-7 has been reported to induce proliferation of thymo-
cytes in addition to carrying out maintenance functions
(Conlon et al., 1989; Murray et al., 1989; Watson et al., wild-type mice were increasingly more involved in cell
cycle progression, as has been described for these1989). TN thymocytes, as well as TN cells subdivided
by CD44 and CD25, were stained with 7-aminoactinomy- same subsets of cells from normal mice (Penit et al.,
1995).cin D (7-AAD), allowing cells with normal DNA content
to be distinguished from cells undergoing mitosis. Table The intracellular Bcl-2 staining in Figure 3 and the cell
cycle data in Table 2 indicate that the influence of the2 shows that whole TN thymocytes from IL-7±deficient
mice showed significantly (p , 0.02) more cells in G0/G1 IL-7 mutation becomes apparent at precisely the same
point in development, the commitment to the T cell lin-and proportionally fewer cells in the S and G2/M phases
of the cell cycle. Subset B (TN CD441CD252), represent- eage, represented by population C (TN CD441CD251).
ing the most immature thymocytes analyzed in this
study, showed no statistical difference (p . 0.5) in the IL-7 Induces Bcl-2 Expression in
IL-7±Deficient Thymocytescell cycle stages between the two groups of mice.
However, each sequential developmental population Since IL-7 is produced by stromal cells, we reasoned
that the thymocytes themselves may not be intrinsicallyshowed statistically significant differences between
IL-7±deficient mice and wild-type mice. These subsets and permanently damaged in IL-7±deficient mice. Cul-
ture of TN thymocytes in rIL-7 in vitro may then ªrevertºof cells from IL-7±deficient mice were more likely to be
in G0/G1 than in S or G2/M. In contrast, the cells from the deficiency of Bcl-2 expression. Figure 5A shows that
Immunity
150
Figure 5. Induction of Bcl-2 Expression in Thymocytes
(A) TN thymocytes from IL-7±deficient mice were purified as de-
scribed and cultured in the presence of 5 ng/ml rIL-7. Bcl-2 expres-
sion was measured by flow cytometry directly ex vivo (open area),
after 1 day (light shaded area), or after 3 days (dark shaded area)
of culturing. The viability of cells after 3 days of culture was greater
than 95%.
(B) DN thymocytes from IL-7±deficient (IL-72/2) and wild-type mice
were purified as described and cultured in the presence of 5 ng/ml
rIL-7 for 3 days. Protein was extracted and analyzed by SDS±Figure 4. Augmented Cell Death in IL-7±Deficient Mice
polyacrylamide gel electrophoresis (12%) followed by Western blot
(A) Immunofluorescence profile from annexin V and PI staining of analysis using Bcl-2 anitbody or ERK2 antibody as a protein loading
TN cells from wild-type and IL-7±deficient (IL-72/2) mice. The data control. Lane 1, freshly isolated cells; lane 2, cells cultured for 3
shown are representative results from three experiments. days.
(B) The percentage of apoptotic cells was measured by staining TN
thymocytes from IL-7±deficient and wild-type mice with annexin V
and PI. The data are the mean 6 SD from three experiments. Paired
t testing showed significant differences between the two groups IL-7 is nonredundant for these processes. Although the
(p , 0.05). multipotential subset B (TN CD441CD252) can respond
to IL-7 (Moore and Zlotnik, 1995), Bcl-2 expression is
similar between wild-type and IL-7±deficient cells. It is
after 1 or 3 days of culture in vitro, rIL-7 significantly only after transition to subset C (TN CD441CD251), cells
induced Bcl-2 expression in TN cells from the IL-7± that are restricted to the T cell lineage but that have not
deficient mice. Cells were more than 95% viable after 3 yet undergone TCR rearrangement, that Bcl-2 becomes
days of culture, whereas culture with no rIL-7 contained dependent on IL-7 signaling. The reduction of cells in
uniformly dead cells (data not shown). As an indepen- the S or G2/M phase of the cell cycle follows the same
dent evaluation, we examined DN thymocytes, a broader pattern among the subsets of thymocytes. Tracing a cell
and more diverse population of immature cells, by West- lineage defect to subset C (TN CD441CD251), but not
ern blot analysis for Bcl-2. Figure 5B shows that DN cells B (TN CD441CD252), is consistent with other findings
from IL-7±deficient mice had substantially less Bcl-2 from IL-7±deficient mice. Natural killer (NK) cells can be
expression than did DN cells from wild-type mice. Both derived from subset B (TN CD441CD252) but not C (TN
wild-type and IL-7±deficient DN cell populations could CD441CD251), and NK cell development is normal in
be cultured with rIL-7, leading to significantly induced IL-7±deficient mice (Moore and Zlotnik, 1995; Moore et
levels of protein. The reexpression of Bcl-2 correlates al., 1996). The nature of the signal to drive cells from
well with IL-7 maintenance of freshly isolated cells in subset B to C is unclear, although signals via the c-Kit
culture (Murray et al., 1989). receptor, perhaps in synergy with IL-7 (Rodewald et al.,
1997) or Flk-2/Flt-3 ligand (Moore and Zlotnik, 1997) may
be candidates.Discussion
Data supporting the in vivo significance of these find-
ings are described in two other reports, where overex-The data presented here provide evidence that IL-7
plays a principal role in regulating Bcl-2 and the cell pression of Bcl-2 leads to restoration of lymphocyte
numbers in IL-7R±deficient mice (Akashi et al., 1997;cycle and specify the transition point where the role for
T Cells Depend on IL-7 for Bcl-2 Expression
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Table 2. Cell Cycle Distribution of TN Thymocytes
Cell Cycle Stage
TN Thymocytes G0/G1 S G2/M
Total Wild-type 69.0 6 1.2 17.0 6 2.0 13.8 6 1.5
IL-7-deficient 84.0 6 3.7 9.5 6 2.1 6.3 6 2.4
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Subset B: CD441CD252 Wild-type 85.6 6 7.7 7.3 6 2.5 7.0 6 4.8
IL-7±deficient 89.0 6 5.3 7.0 6 3.0 4.0 6 2.4
Subset C: CD441CD251 Wild-type 68.5 6 3.7 16.8 6 1.7 15.0 6 3.4
IL-7±deficient 81.3 6 3.2 11.7 6 1.2 7.0 6 1.7
Subset D: CD442CD251 Wild-type 75.3 6 2.5 13.5 6 2.1 11.8 6 1.5
IL-7±deficient 87.0 6 4.6 7.3 6 2.1 6.0 6 2.7
Subset E: CD442CD252 Wild-type 59.0 6 6.3 24.2 6 3.9 16.8 6 2.2
IL-7±deficient 90.7 6 6.7 5.7 6 3.5 4.3 6 3.1
The DNA content of the TN cell population and the gated TN subpopulations were analyzed by 7-AAD staining and flow cytometry in
IL-7±deficient and wild-type mice. Data represent the means 6 SD from three experiments. Paired t test analysis showed significant differences
(p , 0.02) between IL-7±deficient and wild-type mice in the total TN thymocytes as well as in subsets C through E. There was no statistical
difference (p . 0.5) between the data from IL-7±deficient and wild-type mice in subset B.
Maraskovsky et al., 1997). Taken together, these studies apoptosis at the transition of G1 to S (Mazel et al., 1996).
A resolution to these two alternatives rests on an analy-identify the critical step where Bcl-2 expression be-
comes dependent on IL-7 and define the importance sis of the cell cycle in comparable thymocyte subsets
from Bcl-2±deficient mice.of the linking of these pathways in vivo. Because
IL-7R±deficient mice can bind at least two independent
ligands, IL-7 and thymic stromal-derived lymphopoietin
(Peschon et al.,1994; Ray et al., 1996), itwill be important An IL-7/Bcl-2/Cell Cycle Link during Early
Thymic Developmentto confirm exactly where the loss of Bcl-2 expression
occurs in those mice, as we have done with IL-7 ligand± Numerous studies have shown that Bcl-2 expression
correlates with time frames thought to be important indeficient mice in this work. Such an experiment will
determine whether ligands other than IL-7 (either thymic selection mechanisms of the T cell repertoire at the
DP-to-SP stage (Gratiot-Deans et al., 1994; Linette etstromal-derived lymphopoietin or unknown molecules)
play a role in maintaining Bcl-2 expression at a stage al., 1994). While this may be true, we show here that
Bcl-2 expression is dependent on IL-7 signaling at aprior to that at which IL-7 becomes important.
much earlier point in T cell development, immediately
prior to activation of the RAG-1 and RAG-2 genes. Re-Cell Cycle Inhibition in IL-7±Deficient
Thymocyte Subsets cently we have shown that IL-7 producing major histo-
compatibility class II±expressing thymic stromal cellsCoincident with the loss of Bcl-2 protein expression in
the transition to subset C (TN CD441CD251) was a rela- are needed to detect TCRb and TCRg rearrangement,
as measured in reaggregated fetal thymic organ culturetive increase in the percentage of cells in G0/G1. IL-7
has been shown to stimulate the proliferation of cells experiments (Oosterwegel et al., 1997). Thus, the stro-
mal support needed for TCR rearrangement depends(Conlon et al., 1989; Murray et al., 1989; Watson et al.,
1989; Welch et al., 1989), consistent with a reduction in on the ability to produce IL-7. It is difficult to determine
from the present data whether IL-7 directly induces TCRcycling cells in an IL-7±deficient environment. Bcl-2, on
the otherhand, has been shown to inhibit entry to the cell rearrangement as suggested (Muegge et al., 1993), since
maintenance functions may keep cells alive while othercycle when overexpressed in cell culture experiments
(Mazel et al., 1996; O'Reilly et al., 1996), conclusions biochemical mechanisms influence TCR rearrangement.
Nevertheless, a mechanistic role for IL-7 in the timethat are in apparent conflict with the data presented
here. We suggest at least two possible explanations. frame of these events, where numerous pathways may
intersect, is now established.First, IL-7 may be necessary for expression of Bcl-2 to
maintain cell viability, as well as function independently
to stimulate cell proliferation. These may represent di-
vergent pathways. Such a divergence of IL-7 signaling Comparison of Mice Individually Deficient
for IL-7 or Bcl-2separate from a Bcl-2 anti-apoptotic function must exist
for at least some cellular activities (see below). A second Comparison of IL-7± and Bcl-2±deficient mice identify
clear similarities as well as clear differences in theiralternative explanation is that cells leaving G0/G1 to
progress in the cell cycle may be more susceptible to respective phenotypes. It has been reported that the
thymus of adult Bcl-2±deficient mice is reduced in sizeapoptosis, due to loss of Bcl-2 expression, than would
cells remaining in G0/G1. The result of this type of mech- and thymocyte number but unchanged in terms of CD4
and CD8 expression (Veis et al., 1993b; Nakayama etanism would be a relative increase in the proportion of
cells in G0/G1. This interpretation is consistent with the al., 1994; Kamada et al., 1995), a finding similar to that
in IL-7±deficient mice (von Freeden-Jeffry et al., 1995).finding that Bcl-2 protects cells from subsequent
Immunity
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Cell Cycle AnalysisHowever, IL-7±deficient mice are defective in fetal lym-
TN thymocytes were prepared as described above and incubatedphopoiesis in a fashion comparable to adult lymphopoi-
with anti-CD44 (phycoerythrin) and anti-CD25 (fluorescein isothiocy-esis (data not shown). This is not the case for Bcl-2± anate) (both PharMingen) followed by staining with 7-AAD (Calbio-
deficient mice, in which lymphopoiesis declines over chem) as described (Schmid et al., 1991). In brief, cells were fixed
time but appears relatively undisturbed in newborn mice for 1 hr at 48C in 0.25% paraformaldehyde in phosphate-buffered
saline (PBS) and then permeabilized by incubation in PBS/0.2%(Nakayama et al., 1993; Nakayama et al., 1994). In fact,
Tween for 15 min at 378C. DNA was then stained with 7-AAD byBcl-2±deficient fetal liver was able to repopulate recipi-
incubating the cells in PBS containing 25 mg/ml 7-AAD for 30 min.ent animals at least transiently, whereas adult Bcl-2±
Flow cytometry (50,000 cells per sample) was performed on a FACS-
deficient bone marrow cells were unable to do so (Mat- Calibur using a low flow rate. Cell cycle distribution was determined
suzaki et al., 1997). Therefore there is a dependence on using CellQuest software and manual gating.
IL-7 for fetal lymphopoiesis that may not be strictly
Cell Death Analysislinked to Bcl-2. Perhaps other antiapoptotic genes may
Flow cytometry analysis of apoptotic cells was performed with thebe involved with IL-7 signaling. Alternatively, fetal lym-
Apoptosis Detection Kit according to the manufacturer's instruc-
phopoiesis may be more dependent on an IL-7±related tions (R and D Systems). Cells were washed and resuspended in
proliferation function that is unrelated to Bcl-2, as hy- 13 binding buffer at 1 3 106 cells. PI and annexin V were added to
pothesized above. final concentrations of 0.1 and 0.05 mg/ml, respectively, incubated
for 10 min at room temperature, and immediately analyzed on aBcl-2±deficient mice, on the other hand, exhibit obvi-
FACSCalibur.ous abnormalities such as polycystic kidney disease
and defects in hair follicles that cannot be related to IL-7,
Intracellular Bcl-2 Staining
since no such comparable defects occur in IL-7±defi- TN thymocytes were prepared as described above and cultured at
cient mice. Thus, the stimuli to induce or maintain Bcl-2 106 cells/ml in complete RPMI containing 10% fetal calf serum (JR
Scientific), 5 3 105 M 2-mercaptoethanol, (Polysciences, Warrington,expression in these cell types must be different. Based
PA), 2 mM glutamate (JR Scientific), 10 mM HEPES buffer (Irvineon the similarities and differences between the respec-
Scientific), 100 U/ml penicillin, and 100 mg/ml streptomycin (Irvinetive mutant mice, we favor a model in which these two
Scientific) in the presence of 5 ng/ml IL-7 (RandD Systems). Cells
pathways converge during certain developmental time were harvested at 1 and 3 days poststimulation. Both immediately
frames and in particular cell lineages. ex vivo and stimulated cells were stained with anti-CD44 (phyco-
This study identifies critical mechanisms by which erythrin) and anti-CD25 (Red 613) followed by fixation in 2% formal-
dehyde in PBS for 20 min at room temperature. After washing, cellsIL-7 may influence cell viability and the expansion of
were permeabilized by incubation in PBS containing 0.2% bovinecell populations before or coincident with TCR re-
serum albumin and 0.5% saponin (Sigma) for 10 min atroom temper-arrangement. The future challenges of studying these
ature, followed by staining with hamster anti-mouse Bcl-2 mono-
important and complex mechanisms in a physiological clonal antibody (MAb) (PharMingen) (30 minutes, room temperature),
context will require integration of genetic and biochemi- followed by goat anti-hamster IgG (fluorescein isothiocyanate) (Cal-
tag) (30 minutes, room temperature) in the permeabilization solution.cal approaches to reveal how seemingly diverse path-
Cells were washed twice in permeabilization solution and once inways interact.
PBS before analysis by flow cytometry.
Western Blot Analysis
Experimental Procedures DN thymocytes were isolated as described above, cultured at 106
cells/ml in the presence of 5 ng/ml IL-7, and harvested 3 days
Mice poststimulation. Cells were washed twice and pellets were lysed in
The generation and screening of IL-7±deficient mice has been de- 1% Nonidet P-40 lysis buffer (250 mM NaCl, 1 mM HEPES [pH 7.5],
scribed previously (von Freeden-Jeffry et al., 1995). The mice were and 1 mM dithiothreitol [USB]) with protease inhibitors added (final
maintained on C57Bl/6x129 Ola hybrid background. Animals were concentrations: 5 mg/ml aprotinin [Sigma], 125 mg/ml Pefabloc [Boeh-
housed in a specific pathogen±free animal facility and analyzed at ringer Mannheim], 5 mg/ml leupeptin [Sigma], and 5 mg/ml pepstatin
3±4 weeks of age unless otherwise noted. [Sigma]). Proteinconcentration was determined with a Protein Assay
kit (Bio-Rad) according to the manufacturer's instructions. Equal
amounts of protein were loaded on a 12% Tris Glycin Gel (Novex)
Cell Isolation and transferred to nitrocellulose in a Bio-Rad Transblot cell at 48C
TN thymocytes were prepared by lineage depletion using a cocktail overnight at 30 V. Background was reduced by incubation for 1 hr
of biotinylated antibodies (anti-CD3, anti-CD4, anti-CD8a, anti- in 5% milk. Hybridization was carried out in 5% milk for 3 hr using
B220, anti-Gr-1, anti-IgM, anti-Ter-119 [all PharMingen, San Diego, a hamster anti-mouse Bcl-2 MAb or a rabbit anti-mouse ERK2 MAb
CA], anti-Mac-1 [Caltag], and anti-DX5 [DNAX]). After 1 hr of staining as a protein loading control (both PharMingen), followed by incuba-
at 48C, cells were washed and then incubated for 30 minutes at tion for 1 hr with anti-hamster-HRP or anti-rabbit-HRP-Ab (Amer-
48C with magnetic beads coupled with streptavidin protein (Dynal) sham). Immmunoreactive bands were visualized using an epichemi-
according to the manufacturer's protocol. The mixture was then luminescence Western blotting system (Amersham) according to
diluted 4 volumes, and Lin1 cells were removed by magnetic separa- the manufacturer's protocol.
tion. DN thymocytes were prepared by depleting single-cell thymus
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